Table 3 Preoperative serum markers in patients without CBD stones on IOC with and without CBD dilatation on preoperative US
ICO | Patients without stones in CBD | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Preoperative US | CBD <0.8 mm (7 patients) | CBD ≥0.8 mm (22 patients) | |||||||
Normal value | Increased value | Median | Percentiles (25°–75°) | Normal value | Increased value | Median | Percentiles (25°–75°) | P | |
Total bilirubin 3.4–20.5 mmol/L | 1 | 6 | 58.8 | 31.5–118.0 | 10 | 12 | 23.5 | 12.8–41.1 | P > 0.001 |
ALP 40–150 U/L | 3 | 4 | 158.0 | 66.0–479.0 | 11 | 11 | 158.0 | 94.0–176.0 | P > 0.001 |
AST 5–34 U/L | 1 | 6 | 157.0 | 126.0–212.0 | 1 | 21 | 155.5 | 57.5–292.3 | P > 0.001 |
ALT 0–55 U/L | 1 | 6 | 273.0 | 148.0–554.0 | 5 | 17 | 152.5 | 68.5–319.5 | P > 0.001 |
Amylase 30–100 U/L | 0 | 7 | 1013.0 | 572.0–2229.0 | 1 | 21 | 662.5 | 232.8–2146.0 | P > 0.001 |
Lipase 23–300 U/L | 0 | 7 | 3049.0 | 1514.0–4909.0 | 3 | 19 | 2427.0 | 1072.8–4819.6 | P > 0.001 |